Multiple silver linings in spite of a soft Q2 24
15/05/24 -"Coloplast reported softer than expected Q2 24 figures. However, with healthy organic growth, the miss reflected FX headwinds, and, hence, was not that worrisome. Importantly, growth was strong across ..."
Pages
60
Language
English
Published on
15/05/24
You may also be interested by these reports :
26/07/24
No major surprises in H1 FY24 – sales and adjusted EBIT were in-line with consensus, but net income was ~2% lower. At CER, Q2 revenue grew 5.2%yoy, ...
26/07/24
Dräger reported Q2 24 figures bang in line with its preliminary figures. Revenue was up 2%, as the strength in safety was accompanied by some ...
25/07/24
Sartorius Stedim reported a decent set of Q2 figures, meeting estimates. However, the stock has lost over 7% since the announcement, as investors ...
25/07/24
Sartorius reported a decent set of Q2 figures, beating estimates. However, the stock has lost over 8% since the announcement, as investors were ...